Literature DB >> 28626263

11C-Choline positive but 18F-FDG negative pancreatic metastasis from renal cell carcinoma on PET.

Kazuhiro Kitajima1, Kazuhito Fukushima1, Shingo Yamamoto2, Takashi Kato3, Soichi Odawara3, Haruyuki Takaki3, Kaoru Kobayashi3, Toshiko Yamano3, Koichiro Yamakado3, Yukako Nakanishi2, Akihiro Kanematsu2, Michio Nojima2, Kazuhiro Suzumura4, Etsuro Hatano4, Jiro Fujimoto4, Takako Kihara5, Keiji Nakasho6, Seiichi Hirota5, Shozo Hirota3.   

Abstract

Choline is a new PET tracer, which uptake may occur via a choline-specific transporter protein and be accelerated during the proliferation of tumor cells. We report a 61-year-old woman with a metastatic pancreatic tumor from renal cell carcinoma, measuring 35×40 mm. PET scans demonstrated accumulation of 11C-choline in the metastatic pancreatic tumor, but no accumulation of 18F-FDG. Choline PET/CT may play a useful and complementary imaging modality, especially when FDG-PET/CT does not show expected findings or when the evaluation of tumor viability is needed, in patients with renal cell carcinoma.

Entities:  

Keywords:  Choline; FDG; PET; Renal cell carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28626263      PMCID: PMC5472553          DOI: 10.18999/nagjms.79.2.273

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  10 in total

Review 1.  Update on positron emission tomography for imaging of prostate cancer.

Authors:  Kazuhiro Kitajima; Robert C Murphy; Mark A Nathan; Kazuro Sugimura
Journal:  Int J Urol       Date:  2013-09-01       Impact factor: 3.369

2.  Molecular cloning, characterization, and expression in Escherichia coli of a cDNA encoding mammalian choline kinase.

Authors:  T Uchida; S Yamashita
Journal:  J Biol Chem       Date:  1992-05-15       Impact factor: 5.157

3.  Initial experience with 18F-fluoroethylcholine PET/CT in staging and monitoring therapy response of advanced renal cell carcinoma.

Authors:  Marcus Middendorp; Luise Maute; Bruno Sauter; Thomas J Vogl; Frank Grünwald
Journal:  Ann Nucl Med       Date:  2010-04-15       Impact factor: 2.668

4.  Significance of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer.

Authors:  Hideshi Miyakita; Masatosi Tokunaga; Hajime Onda; Yukio Usui; Hidechika Kinoshita; Nobuo Kawamura; Seiei Yasuda
Journal:  Int J Urol       Date:  2002-01       Impact factor: 3.369

Review 5.  Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease.

Authors:  Nicolette K Janzen; Hyung L Kim; Robert A Figlin; Arie S Belldegrun
Journal:  Urol Clin North Am       Date:  2003-11       Impact factor: 2.241

6.  The potential clinical value of FDG-PET for recurrent renal cell carcinoma.

Authors:  Koya Nakatani; Yuji Nakamoto; Tsuneo Saga; Tatsuya Higashi; Kaori Togashi
Journal:  Eur J Radiol       Date:  2009-12-16       Impact factor: 3.528

7.  Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT.

Authors:  Pierpaolo Alongi; Maria Picchio; Fabio Zattoni; Marianna Spallino; Luigi Gianolli; Giorgio Saladini; Laura Evangelista
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-08-14       Impact factor: 9.236

Review 8.  Update on advances in molecular PET in urological oncology.

Authors:  Kazuhiro Kitajima; Shingo Yamamoto; Kazuhito Fukushima; Ryogo Minamimoto; Takao Kamai; Hossein Jadvar
Journal:  Jpn J Radiol       Date:  2016-05-24       Impact factor: 2.374

Review 9.  The role of fluorine-18-fluorodeoxyglucose positron emission tomography in evaluating the response to tyrosine-kinase inhibitors in patients with metastatic primary renal cell carcinoma.

Authors:  Carmelo Caldarella; Barbara Muoio; Maria Antonietta Isgrò; Emilio Porfiri; Giorgio Treglia; Luca Giovanella
Journal:  Radiol Oncol       Date:  2014-07-10       Impact factor: 2.991

10.  Evaluation of 11C-choline PET/CT for primary diagnosis and staging of urothelial carcinoma of the upper urinary tract: a pilot study.

Authors:  Naoto Sassa; Katsuhiko Kato; Shinji Abe; Shingo Iwano; Shinji Ito; Mitsuru Ikeda; Kazuhiro Shimamoto; Seiichi Yamamoto; Tokunori Yamamoto; Momokazu Gotoh; Shinji Naganawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-08       Impact factor: 9.236

  10 in total
  1 in total

Review 1.  Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers.

Authors:  John C Chappell; Laura Beth Payne; W Kimryn Rathmell
Journal:  J Clin Invest       Date:  2019-01-07       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.